These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17518359)

  • 21. Association between immunogenicity and adsorption of a recombinant Streptococcus pneumoniae vaccine antigen by an aluminum adjuvant.
    Levesque PM; Foster K; de Alwis U
    Hum Vaccin; 2006; 2(2):74-7. PubMed ID: 17012880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of adsorbed antigen in mono-valent and combination vaccines.
    Morefield GL; HogenEsch H; Robinson JP; Hem SL
    Vaccine; 2004 May; 22(15-16):1973-84. PubMed ID: 15121310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
    Iyer S; HogenEsch H; Hem SL
    Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing the potency of an alhydrogel-formulated anthrax vaccine by minimizing antigen-adjuvant interactions.
    Watkinson A; Soliakov A; Ganesan A; Hirst K; Lebutt C; Fleetwood K; Fusco PC; Fuerst TR; Lakey JH
    Clin Vaccine Immunol; 2013 Nov; 20(11):1659-68. PubMed ID: 23986317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen.
    Wittayanukulluk A; Jiang D; Regnier FE; Hem SL
    Vaccine; 2004 Mar; 22(9-10):1172-6. PubMed ID: 15003645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of antigen-binding to aluminum adjuvants and the immune response with a novel phosphonate linker.
    Lu F; Boutselis I; Borch RF; Hogenesch H
    Vaccine; 2013 Sep; 31(40):4362-7. PubMed ID: 23887038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and evaluation of a tetravalent botulinum vaccine.
    Shi DY; Liu FJ; Li ZY; Mao YY; Lu JS; Wang R; Pang XB; Yu YZ; Yang ZX
    Hum Vaccin Immunother; 2022 Nov; 18(5):2048621. PubMed ID: 35435814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adsorption onto aluminum hydroxide adjuvant protects antigens from degradation.
    Colaprico A; Senesi S; Ferlicca F; Brunelli B; Ugozzoli M; Pallaoro M; O'Hagan DT
    Vaccine; 2020 Apr; 38(19):3600-3609. PubMed ID: 32063436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detoxification of endotoxin by aluminum hydroxide adjuvant.
    Shi Y; HogenEsch H; Regnier FE; Hem SL
    Vaccine; 2001 Feb; 19(13-14):1747-52. PubMed ID: 11166900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.
    Iyer S; HogenEsch H; Hem SL
    Pharm Dev Technol; 2003; 8(1):81-6. PubMed ID: 12665200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants.
    Art JF; Vander Straeten A; Dupont-Gillain CC
    Int J Pharm; 2017 Jan; 517(1-2):226-233. PubMed ID: 27956190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response.
    Hansen B; Belfast M; Soung G; Song L; Egan PM; Capen R; Hogenesch H; Mancinelli R; Hem SL
    Vaccine; 2009 Feb; 27(6):888-92. PubMed ID: 19071182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced potency of individual and bivalent DNA replicon vaccines or conventional DNA vaccines by formulation with aluminum phosphate.
    Yu YZ; Wang WB; Li N; Wang S; Yu WY; Sun ZW
    Biologicals; 2010 Nov; 38(6):658-63. PubMed ID: 20805035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of protein adsorption on the surface charge characteristics of aluminium-containing adjuvants.
    al-Shakhshir R; Regnier F; White JL; Hem SL
    Vaccine; 1994 Apr; 12(5):472-4. PubMed ID: 8023556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of aluminium hydroxide adjuvant to optimize the adsorption of basic proteins.
    Rinella JV; White JL; Hem SL
    Vaccine; 1996 Mar; 14(4):298-300. PubMed ID: 8744556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a recombinant fusion protein vaccine formulation to protect against Streptococcus pyogenes.
    Morefield G; Touhey G; Lu F; Dunham A; HogenEsch H
    Vaccine; 2014 Jun; 32(30):3810-5. PubMed ID: 24837509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a recombinant Hc of Clostridium botulinum neurotoxin serotype F as an effective subunit vaccine.
    Yu YZ; Li N; Wang RL; Zhu HQ; Wang S; Yu WY; Sun ZW
    Clin Vaccine Immunol; 2008 Dec; 15(12):1819-23. PubMed ID: 18845829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
    Noe SM; Green MA; HogenEsch H; Hem SL
    Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using rate of acid neutralization to characterize aluminum phosphate adjuvant.
    Jiang D; Johnston CT; Hem SL
    Pharm Dev Technol; 2003; 8(4):349-56. PubMed ID: 14601959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.